On Thursday, Eli Lilly and Co. (NYSE:LLY) released data from a Phase 2 trial evaluating the safety and efficacy of eloralintide, an investigational once-weekly, selective amylin receptor agonist, in ...

A scattering of S&P 500 companies has yet to report third quarter results, with most of the reports, including from Nvidia ...

(Reuters) — Indianapolis-based Lilly said on Wednesday it is partnering with Walmart to expand access to Lilly’s weight-loss drug Zepbound, which will be offered for pick-up at Walmart pharmacies ...

Editor's note: The below contains spoilers for IT: Welcome to Derry Episode 1. Stephen King has been writing about nightmarish creatures for over half a century, but his greatest might be Pennywise ...

With the greater part of third quarter earnings results in the rearview mirror, investors are looking closely at marquee ...

Morgan Stanley raised the firm’s price target on Eli Lilly (LLY) to $1,090 from $1,069 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate source for real-time, ...

UBS raised the firm’s price target on Eli Lilly (LLY) to $1,080 from $895 and keeps a Buy rating on the shares. The firm updated its model following the Q3 earnings report. Published first on TheFly – ...

We recently published 10 Stocks on Jim Cramer’s Radar. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. Eli Lilly and Company (NYSE:LLY) continues to be one of ...

Lily James says she stops in her tracks "every time" she watches Alien due to her grandmother's involvement. James' grandma, the actress Helen Horton, voiced the computer known as Mother in Ridley ...

The "Cinderella" star stops in her tracks "every time" she watches the sci-fi classic.

From in-depth workshops to networking opportunities, the 44th edition of the Original Lilly Conference on College Teaching has a little bit of everything for educators, no matter the experience level.

Wall Street expects good news when Lilly announces its Q3 results on Oct. 30. Lilly's stock might not perform as you think it will, even if it beats analysts' estimates. The best approach is to take a ...